Urisec 22
Natural health product licensed in Canada
- Licence holder
- Odan Laboratories Ltd.
- NPN or DIN-HM
- 00396125
- Status
- Active licence
- Licence date
- 6 July 2009
- Revision date
- Not provided
- Form
- Crème
- Route of administration
- Topique
- Application type
- DIN de transition
Oral dose analysis does not apply without an established exclusively oral route.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Monostéarate de glycéryle, Collagène hydrolysé, Cétéareth-12, Laureth sulfate de sodium, Octyldodecanol, Eau purifiée, Lactate de menthyle, diazolidinyl urée, propylèneglycol, Gomme de xanthane, Diméthicone, Parahydroxybenzoate de méthyle, (p)-hydroxybenzoate de propyle, Mineral oil
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Sous-population S/O | Not specified | Not specified | minimum: 2 Tous les jours ; maximum: 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Therapeutic moisturizer for dry skin conditions. Recommended for dry skin areas, especially hands, elbows, feet, knees and diabetic skin care. This non-greasy emollient cream temporarily protects and helps relieve minor skin irritations and itching. Leaves skin smooth, soft and supple. Indications: Local treatment of dry skin conditions, ichthyosis, xerosis, psoriasis, various eczemas, and related hyperkeratotic conditions.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 00396125
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.